This grant supports short-term exploratory clinical trials to improve prevention, diagnosis, or treatment of arthritis, musculoskeletal, or skin diseases through early-stage research.
This grant supports investigator-initiated clinical trials in arthritis, musculoskeletal, or skin diseases, funding both trial preparation and implementation for studies ready to begin.
Funding available for exploratory clinical trials in arthritis, musculoskeletal, and skin diseases; updated application review process.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
NIAMS offers eligible career development award recipients up to $50,000 per year for two years for small research projects supporting a transition to independence; clinical trials are excluded.
Supports investigator-initiated clinical trials for neurological disorders, from early exploratory studies to Phase 3 confirmatory and comparative effectiveness trials.